Products found to contain undeclared medicines
|
| |
| Australia: Safety advisory – Majestic African Mango Capsules |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Majestic African Mango capsules and found that the capsules contain the undeclared substances sibutramine and phenolphthalein.
Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. Phenolphthalein is a prescription-only substance previously marketed as an oral laxative, withdrawn from sale from many markets in the late 1990’s due to concerns over its carcinogenicity with long term use.
The supply of Majestic African Mango capsules containing undisclosed sibutramine and phenolphthalein is illegal.
Majestic African Mango capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/majestic-african-mango-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Saturday, August 05, 2017
Issued at HKT 12:00
|
| |
|
